Ignite Creation Date:
2024-05-06 @ 4:00 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02422199
Status:
UNKNOWN
Last Update Posted:
2018-07-09
First Post:
2015-04-16
Brief Title:
A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2Metastatic Breast Cancer Who Have Prior Received Anthracyclin Taxane or Trastuzumab
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2016-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12
Completion Date Type:
ESTIMATED
First Submit Date:
2015-04-16
First Submit QC Date:
April 20 2015
Study First Post Date:
2015-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-05
Last Update Post Date:
2018-07-09
Last Update Post Date Type:
ACTUAL